Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
961.06
269.49
229.07
100.10
205.97
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
961.06
269.49
229.07
100.10
205.97
0.00
0.00
Raw Material Cost
132.33
65.81
36.71
49.37
40.73
29.05
24.19
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
154.63
119.58
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.08
2.08
2.58
3.10
3.24
0.53
0.00
Selling and Distribution Expenses
590.56
570.43
624.79
537.42
538.26
481.00
400.94
Other Expenses
32.43
39.15
37.18
25.21
30.43
28.62
31.64
Total Expenditure (Excl Depreciation)
1,051.30
1,029.79
1,035.84
842.00
886.53
951.41
861.15
Operating Profit (PBDIT) excl Other Income
-90.19999999999999
-760.3
-806.8000000000001
-741.9
-680.6
-951.4
-861.1
Other Income
-43.54
1.41
33.38
-19.09
34.57
-5.41
4.83
Operating Profit (PBDIT)
-99.06
-723.85
-738.34
-726.86
-614.55
-927.78
-832.13
Interest
4.08
2.08
2.58
3.10
3.24
0.53
0.00
Exceptional Items
0.00
0.00
0.00
0.00
-7.15
-2.00
0.00
Gross Profit (PBDT)
828.72
203.69
192.36
50.73
165.24
-29.05
-24.19
Depreciation
34.72
35.04
35.05
34.13
31.45
29.05
24.19
Profit Before Tax
-137.87
-760.98
-775.97
-764.09
-656.39
-959.35
-856.31
Tax
2.94
2.77
2.85
3.63
2.85
2.89
2.69
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-140.81
-763.75
-778.82
-767.72
-659.24
-962.24
-859.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-140.81
-763.75
-778.82
-767.72
-659.24
-962.24
-859.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-140.81
-763.75
-778.82
-767.72
-659.24
-962.24
-859.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
3,207.49
2,377.01
2,752.50
3,079.62
230.72
690.03
1,652.27
Earnings per share (EPS)
-4.22
-24.66
-26.97
-26.77
-23.95
-34.95
-31.2
Diluted Earnings per share
-4.22
-24.66
-26.97
-26.77
-23.95
-34.95
-31.2
Operating Profit Margin (Excl OI)
-9.39%
-282.12%
-352.2%
-741.19%
-330.42%
0.0%
0.0%
Gross Profit Margin
-10.73%
-269.37%
-323.45%
-729.26%
-303.42%
0.0%
0.0%
PAT Margin
-14.65%
-283.4%
-340.0%
-766.98%
-320.07%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 256.62% vs 17.63% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 81.56% vs 1.94% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 92.35% vs 6.01% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 95.24% vs -19.23% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Stella Pharma Corp. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
961.06
768.50
192.56
25.06%
Other Operating Income
0.00
0.00
0.00
Total Operating income
961.06
768.50
192.56
25.06%
Raw Material Cost
132.33
685.83
-553.50
-80.71%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
608.84
-608.84
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
4.08
0.03
4.05
13,500.00%
Selling and Distribution Expenses
590.56
977.49
-386.93
-39.58%
Other Expenses
32.43
-15.61
48.04
307.75%
Total Expenditure (Excl Depreciation)
1,051.30
2,116.09
-1,064.79
-50.32%
Operating Profit (PBDIT) excl Other Income
-90.25
-1,347.59
1,257.34
93.30%
Other Income
-43.54
84.93
-128.47
-151.27%
Operating Profit (PBDIT)
-99.06
-1,186.82
1,087.76
91.65%
Interest
4.08
0.03
4.05
13,500.00%
Exceptional Items
0.00
-10.49
10.49
100.00%
Gross Profit (PBDT)
828.72
82.67
746.05
902.44%
Depreciation
34.72
75.85
-41.13
-54.23%
Profit Before Tax
-137.87
-1,273.18
1,135.31
89.17%
Tax
2.94
3.81
-0.87
-22.83%
Provisions and contingencies
0
0
0.00
Profit After Tax
-140.81
-1,276.99
1,136.18
88.97%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-140.81
-1,276.99
1,136.18
88.97%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-140.81
-1,276.99
1,136.18
88.97%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
3,207.49
5,190.77
-1,983.28
-38.21%
Earnings per share (EPS)
-4.22
-5.04
0.82
16.27%
Diluted Earnings per share
-4.22
-5.04
0.82
16.27%
Operating Profit Margin (Excl OI)
-9.39%
-175.35%
0.00
165.96%
Gross Profit Margin
-10.73%
-155.80%
0.00
145.07%
PAT Margin
-14.65%
-166.17%
0.00
151.52%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 96.11 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 256.62% vs 17.63% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -14.08 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 81.56% vs 1.94% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -5.55 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 92.35% vs 6.01% in Mar 2024
Annual - Interest
Interest 0.41 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 95.24% vs -19.23% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -9.39%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
